Genetic Signatures Ltd (GSS) — Cash Flow-to-Debt Ratio
Genetic Signatures Ltd (GSS) has a Cash Flow-to-Debt Ratio of -0.07x as of December 2025, meaning its operating cash flow of AU$-349.00K could theoretically repay 0% of its total liabilities (AU$4.95 Million) in one year. Check GSS cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Genetic Signatures Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for Genetic Signatures Ltd across 13 annual periods. Also explore GSS total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Genetic Signatures Ltd (2013–2025)
Year-by-year debt coverage analysis for Genetic Signatures Ltd. For market capitalisation and broader financial context, see Genetic Signatures Ltd (GSS) total market value.
| Year | CF-to-Debt Ratio | Operating CF (AUD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -2.71x | AU$-12.29 Million | AU$4.54 Million | ▼ -65.5% |
| 2024 | -1.64x | AU$-10.12 Million | AU$6.18 Million | ▲ +19.0% |
| 2023 | -2.02x | AU$-12.45 Million | AU$6.16 Million | ▼ -199.9% |
| 2022 | 2.02x | AU$9.81 Million | AU$4.85 Million | ▲ +126.8% |
| 2021 | 0.89x | AU$4.20 Million | AU$4.71 Million | ▲ +135.5% |
| 2020 | -2.51x | AU$-9.49 Million | AU$3.79 Million | ▼ -72.5% |
| 2019 | -1.45x | AU$-2.27 Million | AU$1.56 Million | ▲ +52.4% |
| 2018 | -3.05x | AU$-3.69 Million | AU$1.21 Million | ▼ -41.3% |
| 2017 | -2.16x | AU$-2.57 Million | AU$1.19 Million | ▼ -7.9% |
| 2016 | -2.00x | AU$-2.57 Million | AU$1.28 Million | ▲ +46.7% |
| 2015 | -3.76x | AU$-2.80 Million | AU$743.14K | ▼ -2.9% |
| 2014 | -3.66x | AU$-1.35 Million | AU$370.48K | ▼ -1203.5% |
| 2013 | -0.28x | AU$-1.19 Million | AU$4.23 Million | — |